TY  - CHAP
AU  - Anuratha Sakthianandeswaren
AU  - Polly Sabljak
AU  - Meg J. Elliott
AU  - Michelle Palmieri
and Oliver M. Sieber
ED  - Eva Segelov
Y1  - 2018-11-05
PY  - 2018
T1  - Predictive Biomarkers for Monoclonal Antibody Therapies Targeting EGFR (Cetuximab, Panitumumab) in the Treatment of Metastatic Colorectal Cancer
N2  - An understanding of the molecular pathogenesis of colorectal cancer by researchers and clinicians is essential to facilitate progress in improving patient outcomes in this common cancer that still carries a poor prognosis if not identified early. This book covers the major areas of importance in the field, incorporating new knowledge that has arisen due to the advancement of molecular techniques and the ability to correlate molecular changes with clinical behaviour of tumours. Each chapter is a summary written by experts, concisely summarising current data as well as highlighting potential areas for advancement. Appreciating the differences between tumours on a molecular level is the key to developing and delivering precision medicine, and nowhere is this more critically required than in the field of colorectal cancer.
BT  - Advances in the Molecular Understanding of Colorectal Cancer
SP  - Ch. 6
UR  - https://doi.org/10.5772/intechopen.80690
DO  - 10.5772/intechopen.80690
SN  - 978-1-78985-060-4
PB  - IntechOpen
CY  - Rijeka
Y2  - 2024-04-26
ER  -